UG Stock Overview
Manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
United-Guardian, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$9.65 |
52 Week High | US$16.25 |
52 Week Low | US$6.75 |
Beta | 0.73 |
1 Month Change | -1.03% |
3 Month Change | -38.73% |
1 Year Change | 28.27% |
3 Year Change | -41.09% |
5 Year Change | -50.89% |
Change since IPO | 84.48% |
Recent News & Updates
United-Guardian, Inc. (NASDAQ:UG) Not Doing Enough For Some Investors As Its Shares Slump 29%
Nov 14These Return Metrics Don't Make United-Guardian (NASDAQ:UG) Look Too Strong
Nov 09Earnings Not Telling The Story For United-Guardian, Inc. (NASDAQ:UG) After Shares Rise 26%
Sep 08United-Guardian's (NASDAQ:UG) Upcoming Dividend Will Be Larger Than Last Year's
Jul 22Subdued Growth No Barrier To United-Guardian, Inc.'s (NASDAQ:UG) Price
Jul 15Recent updates
United-Guardian, Inc. (NASDAQ:UG) Not Doing Enough For Some Investors As Its Shares Slump 29%
Nov 14These Return Metrics Don't Make United-Guardian (NASDAQ:UG) Look Too Strong
Nov 09Earnings Not Telling The Story For United-Guardian, Inc. (NASDAQ:UG) After Shares Rise 26%
Sep 08United-Guardian's (NASDAQ:UG) Upcoming Dividend Will Be Larger Than Last Year's
Jul 22Subdued Growth No Barrier To United-Guardian, Inc.'s (NASDAQ:UG) Price
Jul 15United-Guardian (NASDAQ:UG) Has Some Difficulty Using Its Capital Effectively
May 14United-Guardian: Solid Balance Sheet, Solid Dividend, Strong Potential Upside
Feb 20Returns On Capital Signal Difficult Times Ahead For United-Guardian (NASDAQ:UG)
Feb 04United-Guardian, Inc.'s (NASDAQ:UG) Share Price Is Matching Sentiment Around Its Earnings
Dec 29Calculating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)
Nov 07Estimating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)
Jul 18United-Guardian (NASDAQ:UG) Is Achieving High Returns On Its Capital
Mar 07Why We Like The Returns At United-Guardian (NASDAQ:UG)
Nov 11Calculating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)
Oct 12Buying Back Into United-Guardian, Inc.
Aug 15United-Guardian (NASDAQ:UG) Will Pay A Smaller Dividend Than Last Year
May 15United-Guardian: Pristine Balance Sheet, Nice Dividend, But Fully Valued
Apr 11Estimating The Fair Value Of United-Guardian, Inc. (NASDAQ:UG)
Feb 01We Think Shareholders May Want To Consider A Review Of United-Guardian, Inc.'s (NASDAQ:UG) CEO Compensation Package
May 12Do Investors Have Good Reason To Be Wary Of United-Guardian, Inc.'s (NASDAQ:UG) 5.1% Dividend Yield?
Mar 15Should We Be Excited About The Trends Of Returns At United-Guardian (NASDAQ:UG)?
Feb 23Calculating The Fair Value Of United-Guardian, Inc. (NASDAQ:UG)
Feb 02United-Guardian's (NASDAQ:UG) Shareholders Are Down 11% On Their Investment Over The Past Five Years.
Jan 13Is The Market Rewarding United-Guardian, Inc. (NASDAQ:UG) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
Dec 22Our View On United-Guardian's (NASDAQ:UG) CEO Pay
Dec 04United-Guardian cuts dividend by ~14%
Nov 20United-Guardian reports Q3 results
Nov 10Shareholder Returns
UG | US Personal Products | US Market | |
---|---|---|---|
7D | -2.2% | -4.7% | -2.2% |
1Y | 28.3% | -24.7% | 23.9% |
Return vs Industry: UG exceeded the US Personal Products industry which returned -24.7% over the past year.
Return vs Market: UG exceeded the US Market which returned 23.9% over the past year.
Price Volatility
UG volatility | |
---|---|
UG Average Weekly Movement | 8.2% |
Personal Products Industry Average Movement | 8.2% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 17.0% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: UG has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: UG's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1942 | 24 | n/a | www.u-g.com |
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company’s pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology.
United-Guardian, Inc. Fundamentals Summary
UG fundamental statistics | |
---|---|
Market cap | US$44.34m |
Earnings (TTM) | US$3.48m |
Revenue (TTM) | US$12.31m |
12.7x
P/E Ratio3.6x
P/S RatioIs UG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
UG income statement (TTM) | |
---|---|
Revenue | US$12.31m |
Cost of Revenue | US$5.73m |
Gross Profit | US$6.58m |
Other Expenses | US$3.09m |
Earnings | US$3.48m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.76 |
Gross Margin | 53.43% |
Net Profit Margin | 28.30% |
Debt/Equity Ratio | 0% |
How did UG perform over the long term?
See historical performance and comparisonDividends
6.2%
Current Dividend Yield79%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 02:39 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
United-Guardian, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|